Global Malaria News
New research shows how the cyto-adhesion of plasmodium-infected red blood cells is enhanced at febrile temperatures.
Researchers have documented the permissible limits of a number of chemicals that are often part of anti-malarial efficacy tests. Their results provide a previously undetermined dataset on drug reconstitution conditions at which both the red cell integrity and plasmodium growth and proliferation are not compromised.
Scientists have been trying to develop a vaccine that prevents mosquitoes from spreading malaria among humans. This unique approach -- in which immunized humans transfer anti-malarial proteins to mosquitoes when bitten -- is called a transmission-blocking vaccine (TBV). A new biotech advancement moves us closer to this goal.
Malaria-infected red blood cells trigger the immune system's first line of defense by releasing small vesicles that activate a pathogen recognition receptor called MDA5, according to a new study.
A discovery may open up new ways to control steroid hormone-mediated processes, including growth and development in insects, and sexual maturation, immunity, and cancer progression in humans.
Malaria parasites have evolved to be most infectious at the time of day when mosquitoes feed, to maximize their chances of being spread.
Since December 2016, Brazil has been grappling with its worst yellow fever outbreak for several decades. Research has now demonstrated that the yellow fever virus can be transmitted via Aedes albopictus, the tiger mosquito. This opportunistic species is capable of colonizing both urban and forest areas.